Pseudohypoaldosteronism Type II.
Ellison DH.
2011 Nov 10 [updated 2017 Feb 16]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Neonatal Pseudohypoaldosteronism Type-1 in Japan.
Fujioka K, Nakasone R, Nishida K, Ashina M, Sato I, Nozu K.
J Clin Med. 2022 Aug 31;11(17):5135. doi: 10.3390/jcm11175135.
Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature review.
Adachi M, Motegi S, Nagahara K, Ochi A, Toyoda J, Mizuno K.
Endocr J. 2023 Jul 28;70(7):723-729. doi: 10.1507/endocrj.EJ22-0607. Epub 2023 May 19.
[Neonatal systemic pseudohypoaldosteronism type I].
Cao XC, Chen YY, Zhang K, Zhang XJ, Yang L, Li ZH.
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):774-778. doi: 10.7499/j.issn.1008-8830.2305011.
[Pseudohypoaldosteronism type I].
Kaneko K.
Nihon Jinzo Gakkai Shi. 2011;53(2):150-4.
Mechanisms of type I and type II pseudohypoaldosteronism.
Furgeson SB, Linas S.
J Am Soc Nephrol. 2010 Nov;21(11):1842-5. doi: 10.1681/ASN.2010050457. Epub 2010 Sep 9.
Pseudohypoaldosteronism type II: history, arguments, answers, and still some questions.
Healy JK.
Hypertension. 2014 Apr;63(4):648-54. doi: 10.1161/HYPERTENSIONAHA.113.02187. Epub 2014 Jan 6.
[Pseudohypoaldosteronism type I].
Fila M, Amouroux C, Morin D.
Arch Pediatr. 2015 May;22(5 Suppl 1):43-5. doi: 10.1016/S0929-693X(15)30023-3.
Mineralocorticoid resistance.
Zennaro MC, Lombès M.
Trends Endocrinol Metab. 2004 Aug;15(6):264-70. doi: 10.1016/j.tem.2004.06.003.
Gordon's syndrome in pregnancy.
Morton A.
Obstet Med. 2023 Sep;16(3):151-155. doi: 10.1177/1753495X221146331. Epub 2022 Dec 21.
